The global health sector is undergoing rapid transformation, driven by advances in pharmaceutical innovation, digital health technologies, and artificial intelligence, stakeholders say.
Recent developments surrounding glucagon-like peptide-1 (GLP-1) receptor agonists, including Ozempic, have sparked widespread interest among healthcare professionals and patients alike, particularly for their role in managing type 2 diabetes and supporting weight loss.
Originally developed for glycaemic control, GLP-1 drugs are now being increasingly prescribed for obesity treatment, with studies showing significant weight reduction outcomes. Experts, however, caution against misuse and highlight the need for proper medical supervision due to potential side effects such as nausea, gastrointestinal issues, and long-term metabolic concerns.
Meanwhile, the National Health Service (NHS) has continued to expand access to such treatments, while also grappling with rising demand and funding constraints. Health economists note that while GLP-1 medications offer promising outcomes, their high cost poses sustainability challenges for public healthcare systems.
In parallel, the adoption of mental health applications has surged globally, reflecting increased awareness and demand for accessible psychological support. Mobile apps offering therapy, meditation, and mood tracking have become vital tools, particularly among younger populations.
Clinical psychologists emphasise that while these apps provide convenient support, they should complement—not replace—professional care, especially in severe cases of anxiety, depression, and other mental health conditions.
Artificial intelligence is also making significant inroads into diagnostics, improving accuracy and efficiency in disease detection. AI-powered tools are now being deployed to analyse medical imaging, predict disease progression, and assist clinicians in decision-making.
According to health technology analysts, AI diagnostics could help bridge healthcare gaps in underserved regions by enabling faster and more cost-effective screening. However, concerns remain around data privacy, regulatory oversight, and ethical considerations.
In Nigeria, health experts say integrating these innovations into the national healthcare system could enhance service delivery, provided infrastructure and policy frameworks are strengthened.
They called on government and private stakeholders to invest in digital health infrastructure, workforce training, and public awareness to fully harness the benefits of emerging health technologies.
